Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...
A deadly fungal disease has wiped out dozens of frog species worldwide. But new research on disease-resistant frogs in Yosemite National Park could help bring other species back from the brink.
yahoo live match Scientists discover protein that could make opioids safer and less addictive Research progress on new drugs against invasive fungal infections Glucosamine sulfate effervescent tablets ...